Examkin

Soru

Zorluk: OrtaReproductive Endocrinology and Infertility

Match the following clinical presentations of couples experiencing infertility with their most appropriate first-line targeted fertility treatment or management strategy.

  • 30-year-old female with BMI of 33 kg/m², oligoovulation, and clinical hyperandrogenismLetrozole (aromatase inhibitor)
  • 28-year-old female with primary infertility and bilateral hydrosalpinges identified on hysterosalpingographyIn vitro fertilization (IVF)
  • 32-year-old female with secondary amenorrhea, galactorrhea, and a 6-mm pituitary adenoma on MRICabergoline (dopamine agonist)
  • Couple whose male partner has a semen analysis showing a sperm concentration of 2 million/mL with 5% motilityIntracytoplasmic sperm injection (ICSI)

Cevap

PCOS is treated first-line with Letrozole; bilateral tubal factor requires standard IVF; a prolactinoma is managed medically with Cabergoline; and severe male factor infertility (oligospermia/asthenospermia) necessitates ICSI.
Optimal management of infertility requires directing therapy at the underlying pathophysiologic defect. Endocrine abnormalities like PCOS and hyperprolactinemia are managed with targeted pharmacotherapy (letrozole and cabergoline, respectively), while anatomical barriers (tubal occlusion) and severe sperm deficits require specific assisted reproductive technologies (IVF and ICSI).

Adım Adım Çözüm

1
Analyze the clinical presentation to establish the primary mechanism of infertility (ovulatory, tubal, central/endocrine, or male factor).
Identified four distinct etiologies: PCOS (ovulatory), bilateral hydrosalpinges (tubal), prolactinoma (central endocrine), and severe oligospermia/asthenospermia (male factor).
Correctly identifying the anatomic or endocrine defect dictates the specific interventional pathway.
2
Select the standard-of-care, first-line intervention that directly addresses the identified defect.
Matched PCOS to letrozole for ovulation induction, and prolactinoma to cabergoline for medical suppression.
Evidence-based guidelines prioritize targeted medical therapies before invasive or broadly applied assisted reproductive technologies when specific, reversible endocrine issues are identified.
3
Differentiate between indications for standard in vitro fertilization versus those requiring intracytoplasmic sperm injection.
Assigned standard IVF to tubal factor and reserved ICSI for severe male factor infertility.
Tubal factor simply requires bypassing the fallopian tubes (IVF), while severe male factor requires bypassing the sperm's need to independently penetrate the zona pellucida (ICSI).

Anahtar Kavram

Etiology-specific management of infertility algorithms
Bu soruyu puanla

Konular

Reproductive Endocrinology and Infertility

Bu konudan daha fazla soru